Theorem Clinical Research

ICON

New ACRO survey: CRO members saw big growth in past decade

Friday, September 19, 2014 03:34 PM

The biopharmaceutical industry’s outsourcing strategy has enabled the eight members of the Association of Clinical Research Organizations (ACRO) to double in size over the past 10 years, today employing more than 100,000 professionals worldwide with a global payroll of nearly $6 billion.

More... »


Icon’s Cynthia Dukes voted one of the world’s Most Influential People in Vaccines

Thursday, September 18, 2014 12:49 PM

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced that Cynthia Dukes, vice president, global project management, vaccines, infectious disease, women’s health and primary care, has been voted one of the 50 Most Influential People in Vaccines following a global industry survey conducted by vaccine industry organization, VaccineNation. Cynthia was the only CRO representative included in the list.

More... »


Medidata, Icon partner to bring efficiencies to ePRO

Thursday, September 11, 2014 01:40 PM

Medidata, a NewYork-based global provider of cloud-based solutions for clinical research in life sciences, and global CRO Icon have formed a joint initiative designed to bring new efficiencies to the administration of electronic patient-reported outcomes (ePROs) in clinical trials. The new offering provides sponsors with an ePRO solution that reduces costs, saves time and enhances patient engagement.

More... »

Pfizer, Roche join ADDPLAN DF Consortium

Monday, August 4, 2014 02:12 PM

Pfizer and Roche have joined the ADDPLAN DF Consortium. The consortium was founded in 2013 by Novartis, Janssen PharmaceuticalsEli Lilly and Aptiv Solutions, an Icon company, to lead the design and implementation of adaptive trials. The goal of the ADDPLAN DF Consortium is to develop methodologies and execution technologies that improve dose-selection, which remains a major barrier to resolving high failure rates in phase III trials.

More... »

Aptiv Solutions launches ADDPLAN DF 3.0

Wednesday, May 14, 2014 01:35 PM

Aptiv Solutions, an Icon company focused on the design and implementation of adaptive trials, has released ADDPLAN DF 3.0, which incorporates complex statistical methodologies to prevent under- and over-estimation of a therapeutic’s maximum target dose (MTD) during phase I dose escalation trials.

More... »

Icon completes acquisition of Aptiv Solutions

Thursday, May 8, 2014 01:15 PM

CRO Icon has completed its previously announced acquisition of Aptiv Solutions.

More... »

Icon appoints Hugh Brady to board of directors

Wednesday, April 30, 2014 03:11 PM

CRO Icon has appointed Dr. Hugh Brady as a non-executive director on the board of directors.

More... »

Icon’s Firecrest training recognized by TransCelerate BioPharma

Monday, April 14, 2014 10:13 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced that its Firecrest training meets TransCelerate BioPharma’s minimum criteria for International Conference on Harmonization Good Clinical Practice (ICH/GCP) training.

More... »

Icon awarded best CRO at World Vaccines Congress 2014

Thursday, April 3, 2014 11:33 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has been named Best Clinical Research Organization in the Vaccine Industry Excellence (ViE) Awards.

More... »

Icon acquires Aptiv Solutions to strengthen adaptive design capabilities

Monday, March 31, 2014 03:04 PM

Seeking to enhance its capabilities in the design and execution of portfolio-wide adaptive clinical trials for pharmaceutical, biotech and medical device companies, Icon has agreed to acquire Aptiv Solutions, a global services company focused on enhancing clinical trial decision-making, for $143.5 million in cash.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 27

NIH’s I-Corps boot camp aims to transform researchers into better businesspeople before they launch products

Covance, Frenova form partnership to share patient databases, find effective treatments for renal disease

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs